Cargando…
Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data
BACKGROUND: Pathway enrichment analysis (PEA) is a well-established methodology for interpreting a list of genes and proteins of interest related to a condition under investigation. This paper aims to extend our previous work in which we introduced a preliminary comparative analysis of pathway enric...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482563/ https://www.ncbi.nlm.nih.gov/pubmed/34592927 http://dx.doi.org/10.1186/s12859-021-04297-z |
_version_ | 1784576934357762048 |
---|---|
author | Agapito, Giuseppe Cannataro, Mario |
author_facet | Agapito, Giuseppe Cannataro, Mario |
author_sort | Agapito, Giuseppe |
collection | PubMed |
description | BACKGROUND: Pathway enrichment analysis (PEA) is a well-established methodology for interpreting a list of genes and proteins of interest related to a condition under investigation. This paper aims to extend our previous work in which we introduced a preliminary comparative analysis of pathway enrichment analysis tools. We extended the earlier work by providing more case studies, comparing BiP enrichment performance with other well-known PEA software tools. METHODS: PEA uses pathway information to discover connections between a list of genes and proteins as well as biological mechanisms, helping researchers to overcome the problem of explaining biological entity lists of interest disconnected from the biological context. RESULTS: We compared the results of BiP with some existing pathway enrichment analysis tools comprising Centrality-based Pathway Enrichment, pathDIP, and Signaling Pathway Impact Analysis, considering three cancer types (colorectal, endometrial, and thyroid), for a total of six datasets (that is, two datasets per cancer type) obtained from the The Cancer Genome Atlas and Gene Expression Omnibus databases. We measured the similarities between the overlap of the enrichment results obtained using each couple of cancer datasets related to the same cancer. CONCLUSION: As a result, BiP identified some well-known pathways related to the investigated cancer type, validated by the available literature. We also used the Jaccard and meet-min indices to evaluate the stability and the similarity between the enrichment results obtained from each couple of cancer datasets. The obtained results show that BiP provides more stable enrichment results than other tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-021-04297-z. |
format | Online Article Text |
id | pubmed-8482563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84825632021-09-30 Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data Agapito, Giuseppe Cannataro, Mario BMC Bioinformatics Research BACKGROUND: Pathway enrichment analysis (PEA) is a well-established methodology for interpreting a list of genes and proteins of interest related to a condition under investigation. This paper aims to extend our previous work in which we introduced a preliminary comparative analysis of pathway enrichment analysis tools. We extended the earlier work by providing more case studies, comparing BiP enrichment performance with other well-known PEA software tools. METHODS: PEA uses pathway information to discover connections between a list of genes and proteins as well as biological mechanisms, helping researchers to overcome the problem of explaining biological entity lists of interest disconnected from the biological context. RESULTS: We compared the results of BiP with some existing pathway enrichment analysis tools comprising Centrality-based Pathway Enrichment, pathDIP, and Signaling Pathway Impact Analysis, considering three cancer types (colorectal, endometrial, and thyroid), for a total of six datasets (that is, two datasets per cancer type) obtained from the The Cancer Genome Atlas and Gene Expression Omnibus databases. We measured the similarities between the overlap of the enrichment results obtained using each couple of cancer datasets related to the same cancer. CONCLUSION: As a result, BiP identified some well-known pathways related to the investigated cancer type, validated by the available literature. We also used the Jaccard and meet-min indices to evaluate the stability and the similarity between the enrichment results obtained from each couple of cancer datasets. The obtained results show that BiP provides more stable enrichment results than other tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12859-021-04297-z. BioMed Central 2021-09-30 /pmc/articles/PMC8482563/ /pubmed/34592927 http://dx.doi.org/10.1186/s12859-021-04297-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Agapito, Giuseppe Cannataro, Mario Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title | Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title_full | Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title_fullStr | Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title_full_unstemmed | Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title_short | Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data |
title_sort | using biopax-parser (bip) to enrich lists of genes or proteins with pathway data |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482563/ https://www.ncbi.nlm.nih.gov/pubmed/34592927 http://dx.doi.org/10.1186/s12859-021-04297-z |
work_keys_str_mv | AT agapitogiuseppe usingbiopaxparserbiptoenrichlistsofgenesorproteinswithpathwaydata AT cannataromario usingbiopaxparserbiptoenrichlistsofgenesorproteinswithpathwaydata |